Effect of preoperative paracetamol on gastric volumes and pH in children

Insights

Preoperative paracetamol elixir does not affect gastric contents in children undergoing adenotonsillectomy. This study found no significant difference in gastric volume or pH between elixir and suppository administration, supporting preoperative use.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacokinetics
  • Gastrointestinal Physiology

Background:

  • The impact of preoperative oral paracetamol on pediatric gastric contents is not well-established.
  • Understanding gastric content changes is crucial for anesthetic safety, particularly regarding aspiration risk.

Purpose of the Study:

  • To investigate the effect of preoperative paracetamol elixir administration on gastric volume and pH in children.
  • To compare the gastric effects of preoperative paracetamol elixir versus intraoperative paracetamol suppositories.

Main Methods:

  • Children undergoing elective adenotonsillectomy were randomized to receive either paracetamol elixir or suppositories.
  • Gastric residual volume and pH were measured after anesthetic induction using an orogastric tube.
  • Data analysis compared mean residual gastric volume and pH between the two groups.

Main Results:

  • No significant difference was observed in mean residual gastric volume (0.083 ml/kg) or pH between the elixir and suppository groups.
  • Paracetamol elixir was rapidly absorbed, indicating no significant alteration of gastric contents prior to surgery.
  • The study included children with a mean age of 8.5 years and weight of 35 kg.

Conclusions:

  • Preoperative administration of paracetamol elixir does not alter gastric contents in pediatric patients.
  • Rapid gastrointestinal absorption suggests paracetamol elixir can be safely administered preoperatively for routine procedures.
  • This finding supports the use of preoperative paracetamol elixir for analgesia in pediatric surgical patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...